Klin Farmakol Farm. 2011;25(2):85-86

Treatment of peripheral neuropathic pain

Jan Lejčko
ARK, Centrum léčby bolesti, Anesteziologicko-resuscitační klinika FN Plzeň

Neuropathic pain (NPB) is almost always long and difficult one among the modifiable forms of chronic pain. The clinical picture is very

varied and individually specific. Moreover of the antineurophatic agents with the potential to affect the substance of the specific pathophysiology

of acute abdomen is the credo of contemporary pharmacotherapy. For most types of ACC are now the first choice of most

gabapentinoids. Recently, several new options appeared effective local treatment of peripheral NPB. This treatment option is especially

for patients with extensive polymorbid pharmacotherapy, the overall optimal solution.

Keywords: neuropathic pain, pharmacotherapy, gabapentinoids, local treatment

Published: June 20, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lejčko J. Treatment of peripheral neuropathic pain. Klin Farmakol Farm. 2011;25(2):85-86.
Download citation

References

  1. Treede RD, Jensen TS, et al. Redefinition of neuropathic pain and a grading system for clinical use: consensus statement on clinical and research diagnostic criteria. Neurology 2008; 70: 1630-1635. Go to original source... Go to PubMed...
  2. Attal N, Cruccu GR Baron, Haanpää M, Hansson P, Jensen TS, Nurmikko T. EFNS guidelines on pharmacological treatment of neuropathic pain: 2009 revision. Eur J Neurol 2009 revision; 13: 1153-1169. Go to original source... Go to PubMed...
  3. Farrar J, Young JP Jr, La Moreaux R, Werth JL, Poole RM. Clinical importance of chronic changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149-58. Go to original source... Go to PubMed...




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.